Edition:
India

Vascular Biogenics Ltd (VBLT.OQ)

VBLT.OQ on NASDAQ Stock Exchange Global Market

6.70USD
2:29am IST
Change (% chg)

$-0.10 (-1.47%)
Prev Close
$6.80
Open
$6.85
Day's High
$6.85
Day's Low
$6.62
Volume
38,466
Avg. Vol
54,428
52-wk High
$9.05
52-wk Low
$3.95

Select another date:

Fri, Nov 17 2017

BRIEF-VBL therapeutics prices 2.5 mln ordinary share offering

* VBL Therapeutics prices 2.5 million ordinary share offering

BRIEF-VBL Therapeutics announces proposed public offering of 2.5 mln shares of ordinary shares

* VBL Therapeutics announces proposed public offering of 2.5 million shares of ordinary shares Source text for Eikon: Further company coverage:

BRIEF-VBL therapeutics Q3 loss per share $0.24

* VBL Therapeutics announces third quarter 2017 financial results

BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

* VBL Therapeutics and Nanocarrier Co Ltd sign exclusive agreement for VB-111 in Japan

BRIEF-VBL THERAPEUTICS OPENS NEW GENE THERAPY MANUFACTURING PLANT, HEADQUARTERS

* VBL THERAPEUTICS CELEBRATES OPENING OF ITS NEW GENE THERAPY MANUFACTURING PLANT AND COMPANY HEADQUARTERS

BRIEF-VBL Therapeutics says VB-111 given orphan drug designation in Europe

* VBL Therapeutics announces orphan drug designation for VB-111 in Europe

BRIEF-Vascular Biogenics reports Q2 loss per share $0.18

* Vbl therapeutics announces second quarter 2017 financial results

BRIEF-VBL Therapeutics provides update on long-term survival in phase 2 trials of patients with multiple tumor types

* VBL Therapeutics provides update on long-term survival in phase 2 trials of patients with multiple tumor types

Select another date: